Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: Results of SMC NB-2004 study

@article{Sung2013TandemHC,
  title={Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: Results of SMC NB-2004 study},
  author={Ki Woong Sung and Myeong Ha Son and Suck Hong Lee and Keon Hee Yoo and Hong Hoe Koo and Jong Yeop Kim and Eun Joo Cho and Say Kiat Lee and Youn Su Choi and Do Hoon Lim and Dong Won Kim},
  journal={Bone Marrow Transplantation},
  year={2013},
  volume={48},
  pages={68-73}
}
From January 2004 to December 2008, 50 consecutive patients with high-risk neuroblastoma were assigned to receive tandem HDCT (high-dose chemotherapy)/auto-SCT after nine cycles of induction chemotherapy. CEC (carboplatin+etoposide+cyclophosphamide) regimen and TM (thiotepa+melphalan)-TBI regimen (or TM regimen for stage 3 patients) were the first and second HDCT regimens. Local radiotherapy, differentiation therapy with 13-cis-retinoid acid and immunotherapy with interleukin-2 were given after… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Similar Papers

Loading similar papers…